Your browser doesn't support javascript.
loading
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Colomba, Emeline; Jonas, Sarah Flora; Eymard, Jean-Christophe; Delva, Rémi; Brachet, Pierre Emmanuel; Neuzillet, Yann; Penel, Nicolas; Roubaud, Guilhem; Bompas, Emmanuelle; Mahammedi, Hakim; Longo, Raffaelle; Helissey, Carole; Barthélemy, Philippe; Borchiellini, Delphine; Hasbini, Ali; Priou, Franck; Saldana, Carolina; Voog, Eric; Narcisso, Bérangère; Ladoire, Sylvain; Berdah, Jean-François; Aisenfarb, Jean-Baptiste; Foulon, Stéphanie; Fizazi, Karim.
Afiliación
  • Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France. Electronic address: emeline.colomba-blameble@gustaveroussy.fr.
  • Jonas SF; Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France.
  • Eymard JC; Institut Jean Godinot, Reims, France.
  • Delva R; ICO Paul Papin, Angers, France.
  • Brachet PE; Center François Baclesse, Caen, France.
  • Neuzillet Y; Department of Urology, Hospital Foch, University of Paris Saclay - UVSQ, Suresnes, France.
  • Penel N; Lille University, Lille, France; Centre Oscar Lambret, Lille, France.
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Bompas E; ICO René Gauducheau, Saint Herblain, France.
  • Mahammedi H; Centre Jean Perrin, Clermont Ferrand, France.
  • Longo R; Hôpital de Mercy, Metz, France.
  • Helissey C; HIA Bégin, Saint Mandé, France.
  • Barthélemy P; Strasbourg Hopital Civil, Strasbourg, France.
  • Borchiellini D; Centre Antoine Lacassagne, Nice, France.
  • Hasbini A; Clinique Pasteur De Brest CFRO, Brest, France.
  • Priou F; CHD de Vendée, La Roche sur Yon, France.
  • Saldana C; Hôpital Henri Mondor, Créteil, France.
  • Voog E; Centre Jean Bernard, Le Mans, France.
  • Narcisso B; CHU Bretonneau, Tours, France.
  • Ladoire S; Centre Georges François Leclerc, Dijon, France.
  • Berdah JF; Hôpital Privé, HPTH, Sainte Marguerite, Hyères, France.
  • Aisenfarb JB; Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.
  • Foulon S; Biostatistics and Epidemiology Department, Gustave Roussy, Paris Saclay University, Villejuif, France.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
Eur Urol ; 85(3): 274-282, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37271630
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Pirazoles / Benzamidas / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Pirazoles / Benzamidas / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article Pais de publicación: Suiza